Applied DNA Sciences Inc reports results for the quarter ended December 31 - Earnings Summary

• Applied DNA Sciences Inc APDN.OQ reported a quarterly adjusted loss of 56 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.80. The mean expectation of two analysts for the quarter was for a loss of 32 cents per share. Wall Street expected results to range from -33 cents to -32 cents per share.

• Revenue rose 34.3% to $1.20 million from a year ago; analysts expected $1.04 million.

• Applied DNA Sciences Inc's reported EPS for the quarter was a loss of 56 cents​.

• Applied DNA Sciences Inc shares had fallen by 7.0% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

This summary was machine generated from LSEG data February 13 at 10:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)